- Home
- WLGS vs NLSP Comparison
WLGS vs NLSP Comparison
Compare WLGS & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLGS
- NLSP
- Stock Information
- Founded
- WLGS 1981
- NLSP 2015
- Country
- WLGS Hong Kong
- NLSP Switzerland
- Employees
- WLGS N/A
- NLSP N/A
- Industry
- WLGS Engineering & Construction
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- WLGS Consumer Discretionary
- NLSP Health Care
- Exchange
- WLGS Nasdaq
- NLSP Nasdaq
- Market Cap
- WLGS 22.2M
- NLSP 243.8M
- IPO Year
- WLGS 2023
- NLSP 2021
- Fundamental
- Price
- WLGS $2.58
- NLSP $4.96
- Analyst Decision
- WLGS
- NLSP
- Analyst Count
- WLGS 0
- NLSP 0
- Target Price
- WLGS N/A
- NLSP N/A
- AVG Volume (30 Days)
- WLGS 269.6K
- NLSP 34.6K
- Earning Date
- WLGS 11-14-2024
- NLSP 11-01-2024
- Dividend Yield
- WLGS N/A
- NLSP N/A
- EPS Growth
- WLGS N/A
- NLSP N/A
- EPS
- WLGS N/A
- NLSP N/A
- Revenue
- WLGS $6,825,879.00
- NLSP N/A
- Revenue This Year
- WLGS N/A
- NLSP N/A
- Revenue Next Year
- WLGS N/A
- NLSP N/A
- P/E Ratio
- WLGS N/A
- NLSP N/A
- Revenue Growth
- WLGS 63.69
- NLSP N/A
- 52 Week Low
- WLGS $0.40
- NLSP $4.08
- 52 Week High
- WLGS $4.20
- NLSP $29.68
- Technical
- Relative Strength Index (RSI)
- WLGS 58.66
- NLSP 46.37
- Support Level
- WLGS $2.33
- NLSP $4.52
- Resistance Level
- WLGS $4.20
- NLSP $5.64
- Average True Range (ATR)
- WLGS 0.65
- NLSP 0.48
- MACD
- WLGS 0.04
- NLSP 0.07
- Stochastic Oscillator
- WLGS 34.29
- NLSP 55.44
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.